Weaver C. Barksdale & Associates’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$10K Buy
479
+1
+0.2% +$20 0.01% 277
2017
Q3
$9K Hold
478
0.01% 285
2017
Q2
$9K Buy
478
+81
+20% +$1.58K 0.01% 285
2017
Q1
$8K Sell
397
-68
-15% -$1.43K 0.01% 311
2016
Q4
$9K Buy
465
+20
+4% +$364 0.01% 290
2016
Q3
$8K Buy
445
+5
+1% +$86 0.01% 299
2016
Q2
$7K Buy
440
+48
+12% +$763 0.01% 299
2016
Q1
$6K Hold
392
﹤0.01% 353
2015
Q4
$6K Buy
392
+5
+1% +$81 ﹤0.01% 347
2015
Q3
$6K Buy
387
+9
+2% +$143 ﹤0.01% 341
2015
Q2
$6K Buy
378
+39
+12% +$682 ﹤0.01% 356
2015
Q1
$6K Buy
339
+25
+8% +$441 ﹤0.01% 361
2014
Q4
$6K Sell
314
-78
-20% -$1.3K ﹤0.01% 343
2014
Q3
$5K Buy
392
+16
+4% +$233 ﹤0.01% 364
2014
Q2
$5K Buy
376
+54
+17% +$789 ﹤0.01% 379
2014
Q1
$5K Buy
322
+36
+13% +$574 ﹤0.01% 379
2013
Q4
$5K Sell
286
-50
-15% -$733 ﹤0.01% 381
2013
Q3
$4K Sell
336
-42
-11% -$498 ﹤0.01% 411
2013
Q2
$4K Buy
+378
New +$4.26K ﹤0.01% 406

Other funds holding GNTX

Weaver C. Barksdale & Associates's GNTX Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Gentex (GNTX) stake by 0.21% in Q4 2017, buying an estimated $20 and bringing the position to 479 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #277.

Weaver C. Barksdale & Associates first reported a position in GNTX in Q2 2013 and has held it in 19 quarters since. 443 funds tracked by Wall St. Rank hold GNTX as of Q4 2017.

  • Weaver C. Barksdale & Associates held 479 shares of Gentex worth $10K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 1 Gentex share in Q4 2017, an estimated $20.
  • Gentex made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #277 holding.
  • Weaver C. Barksdale & Associates first reported a position in Gentex in Q2 2013 and has held it in 19 quarters since.
  • 443 funds tracked by Wall St. Rank held Gentex as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.